ADIPOQ and hepatocellular carcinoma: Elevated serum adiponectin has been documented in various liver diseases, including acute hepatitis, chronic hepatitis, liver cirrhosis, hepatocellular carcinoma, and primary biliary cirrhosis [11,30-32].